Back to stories
Industry

Babuschkin's River AI Seeks $1B at $5B Valuation, General Catalyst in Talks to Lead

Michael Ouroumis2 min read
Babuschkin's River AI Seeks $1B at $5B Valuation, General Catalyst in Talks to Lead

xAI co-founder Igor Babuschkin is raising up to $1 billion for a new AI startup, River AI, at a valuation of up to $5 billion, according to Forbes reporting circulating this week. General Catalyst is in talks to lead the round, and Babuschkin himself is committing up to $100 million of his own capital.

The specifics

River AI was incorporated in Nevada on April 20, 2026. Neither Babuschkin nor General Catalyst responded to Forbes for comment, and the article explicitly notes that River AI's technical roadmap and product plans have not been disclosed. The funding target — $1 billion at a $5 billion pre-money — would put River AI in the upper tier of seed-stage frontier-lab rounds, on par with the early raises that launched Thinking Machines Lab and Safe Superintelligence.

Babuschkin announced his exit from xAI in August 2025 and initially positioned his next act as Babuschkin Ventures, an AI safety–focused VC firm that Elon Musk pledged $200 million toward as a limited partner. River AI appears to be a separate operating company rather than a portfolio bet, signalling that Babuschkin intends to ship models, not just write checks.

Context: the xAI co-founder exodus

River AI's emergence caps a near-complete co-founder turnover at xAI. By multiple counts, every one of the eleven (some sources say twelve) original xAI co-founders has now departed, with the most recent exits accelerating after SpaceX's acquisition consolidated control under Musk's umbrella.

Babuschkin's pedigree matters for the raise. As chief engineer, he owned the technical architecture that connected the Colossus supercluster's 200,000-plus GPU array to xAI's training stack — the work that put Grok on a competitive curve in 2024–2025. That operational track record is what underwrites a $5 billion mark on a company with no public product.

What changes for builders

The neolab pattern — small, researcher-led entities raising nine- to ten-figure seeds at multibillion-dollar valuations — is now the dominant funding modality for ex-frontier-lab talent. Babuschkin joins Mira Murati's Thinking Machines, Ilya Sutskever's SSI, and David Silver's Ineffable Intelligence in compressing the gap between "resignation announcement" and "hyperscaler-adjacent compute commitment" to under twelve months.

For enterprise buyers and infrastructure teams, the practical signal is supply-side: another lab with $1 billion of dry powder will compete for the same GB300 allocation, the same data-center power, and the same senior researcher headcount the four incumbents are already bidding on. Expect downstream pressure on training-cluster lead times and senior IC compensation through the back half of 2026.

General Catalyst's lead, if it closes, also continues the firm's pattern of writing the largest checks for solo-founder labs rather than diversifying across the agentic and applied layers.

Learn AI for Free — FreeAcademy.ai

Take "AI for Business: Practical Implementation" — a free course with certificate to master the skills behind this story.

More in Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI
Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI

At I/O 2026, Google relaunched Antigravity as a standalone agent-orchestration platform with a CLI that replaces the Gemini CLI, an SDK, Managed Agents in the Gemini API, and an enterprise tier — all defaulting to Gemini 3.5 Flash.

10 min ago2 min read
Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max
Industry

Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max

Alibaba's chip unit T-Head unveiled the Zhenwu M890 AI accelerator, claiming 3x the agentic-inference performance of Nvidia's H20 and 144GB of HBM3, paired with the Qwen 3.7-Max model — a full domestic stack as US export controls tighten.

1 hours ago2 min read
Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents
Industry

Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents

Cohere has acquired Montréal- and Berlin-based biopharma startup Reliant AI, folding its automated research workbench into the North platform to launch 'North for Pharma' — its second acquisition in a month as it doubles down on sovereign, regulated-industry AI.

3 hours ago2 min read